Skip to main content

Drug Interactions between imiglucerase and Yargesa

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

imiglucerase migLUstat

Applies to: imiglucerase and Yargesa (miglustat)

Ask your doctor before using imiglucerase together with migLUstat. Using these medications together can decrease the effects of imiglucerase. Contact your doctor if your condition worsens. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

migLUstat food

Applies to: Yargesa (miglustat)

Food may delay and/or reduce the absorption of miglustat (brand name Opfolda). This brand of miglustat should be administered on an empty stomach with unsweetened beverages (e.G., water, tea or coffee with no cream, sugar, or sweeteners) at least 2 hours before or 2 hours after food. Other miglustat products (brand names Zavesca and Yargesa) can be taken with or without food. MigLUstat may also cause diarrhea. Talk to your doctor if you are experiencing diarrhea or other digestive problems. Your doctor may suggest a dose adjustment, taking your medication between meals, and/or modifying your diet to have less sucrose, lactose, and other carbohydrates. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.

Duplication

Agents for gaucher disease

Therapeutic duplication

The recommended maximum number of medicines in the 'agents for Gaucher disease' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'agents for Gaucher disease' category:

  • imiglucerase
  • Yargesa (miglustat)

Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer